human miltenyi 130 046 703 cd45 fitc bd biosciences 555482 (Miltenyi Biotec)
97
Structured Review
Miltenyi Biotec
human miltenyi 130 046 703 cd45 fitc bd biosciences 555482
Human Miltenyi 130 046 703 Cd45 Fitc Bd Biosciences 555482, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1629 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34+fitc/CD34+MicroBead+Kit%2C+human/pm41903134-239-62-63
Average 97 stars, based on 1629 article reviews
Human Miltenyi 130 046 703 Cd45 Fitc Bd Biosciences 555482, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1629 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34+fitc/CD34+MicroBead+Kit%2C+human/pm41903134-239-62-63
Average 97 stars, based on 1629 article reviews
human miltenyi 130 046 703 cd45 fitc bd biosciences 555482 - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Isolation:Article Title: Isolated naive pluripotent stem cells and methods of generating same Article Snippet: .. Hematopoietic cells are isolated using fluorescently-labeled antibodies such as Incubation:Article Title: Robust differentiation and potent immunomodulation of human mesenchymal stromal cells cultured with a xeno-free GMP protein supplement. Article Snippet: Background/Aims: Human mesenchymal stromal cells (hMSC) are multipotent adult cells commonly used in regenerative medicine as advanced therapy medicinal products.. The expansion of these cells in xeno-free supplements is highly encouraged by regulatory agencies due to safety concerns.. However, the number of supplements with robust performance and consistency for hMSC expansion are limited. Article Title: Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy? Article Snippet: Strategies to improve hematopoietic stem and progenitor cell (HSPC) mobilization from the bone marrow can have a pivotal role in addressing iatrogenic bone-marrow insufficiency from chemo(radio)therapy and overcoming peripheral blood stem cell transplantation (PBSCT) limitations such as insufficient mobilization.. Granulocyte-colony stimulating factor (G-CSF) represents the standard mobilization strategy for HSPC and has done so for more than three decades since its FDA approval.. Its association with non–G-CSF agents is often employed for difficult HSPC mobilization. Bioprocessing:Article Title: Robust differentiation and potent immunomodulation of human mesenchymal stromal cells cultured with a xeno-free GMP protein supplement. Article Snippet: Background/Aims: Human mesenchymal stromal cells (hMSC) are multipotent adult cells commonly used in regenerative medicine as advanced therapy medicinal products.. The expansion of these cells in xeno-free supplements is highly encouraged by regulatory agencies due to safety concerns.. However, the number of supplements with robust performance and consistency for hMSC expansion are limited. Article Title: Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy? Article Snippet: Strategies to improve hematopoietic stem and progenitor cell (HSPC) mobilization from the bone marrow can have a pivotal role in addressing iatrogenic bone-marrow insufficiency from chemo(radio)therapy and overcoming peripheral blood stem cell transplantation (PBSCT) limitations such as insufficient mobilization.. Granulocyte-colony stimulating factor (G-CSF) represents the standard mobilization strategy for HSPC and has done so for more than three decades since its FDA approval.. Its association with non–G-CSF agents is often employed for difficult HSPC mobilization. FACS:Article Title: Transcriptional Responses of In Vitro Blood–Brain Barrier Models to Shear Stress Article Snippet: .. Cells were then lifted and sorted via magnetic activated cell sorting (MACS) using the Stem Cell Technologies EasySep Human FITC Positive Selection Kit II (Gibco, Waltham, MA, USA), using either the Article Title: Transcriptional Responses of In Vitro Blood-Brain Barrier Models to Shear Stress. Article Snippet: .. Cells were then lifted and sorted via magnetic activated cell sorting (MACS) using the Stem Cell Technologies EasySep Human FITC Positive Selection Kit II (Gibco, Waltham, MA, USA), using either the Magnetic Cell Separation:Article Title: Transcriptional Responses of In Vitro Blood–Brain Barrier Models to Shear Stress Article Snippet: .. Cells were then lifted and sorted via magnetic activated cell sorting (MACS) using the Stem Cell Technologies EasySep Human FITC Positive Selection Kit II (Gibco, Waltham, MA, USA), using either the Article Title: Transcriptional Responses of In Vitro Blood-Brain Barrier Models to Shear Stress. Article Snippet: .. Cells were then lifted and sorted via magnetic activated cell sorting (MACS) using the Stem Cell Technologies EasySep Human FITC Positive Selection Kit II (Gibco, Waltham, MA, USA), using either the Selection:Article Title: Transcriptional Responses of In Vitro Blood–Brain Barrier Models to Shear Stress Article Snippet: .. Cells were then lifted and sorted via magnetic activated cell sorting (MACS) using the Stem Cell Technologies EasySep Human FITC Positive Selection Kit II (Gibco, Waltham, MA, USA), using either the Article Title: Transcriptional Responses of In Vitro Blood-Brain Barrier Models to Shear Stress. Article Snippet: .. Cells were then lifted and sorted via magnetic activated cell sorting (MACS) using the Stem Cell Technologies EasySep Human FITC Positive Selection Kit II (Gibco, Waltham, MA, USA), using either the Amplification:Article Title: Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa Article Snippet: FORWARD ** AATGATACGGCGACCACCGAG ATCTACACTCTTTCCCTACACG ACGCTC locus-specific amplification SHORT_INT_FOR ** AATGATACGGCGACCACCGAG ATCT locus-specific amplification JAK2_PRIMER1 ** ACCAACCTCACCAACATTACAG AGGCCT locus-specific amplification JAK2_PRIMER2 ** AGGAGACTACGGTCAACTGCA TGAAACAGA locus-specific amplification JAK2_PRIMER3 ** GCAGCAAGTATGATGAGCAAG CTTTCTCACA locus-specific amplification JAK2_PRIMER4 ** GTGACTGGAGTTCAGACGTGT GCTCTTCCGATCTGCAGCAAG TATGATGAGCAA locus-specific amplification Table S4: List of all antibodies used for flow cytometry Antibody, clone Company Dilutio n CD235a-PC7, 11E4B Beckman Coulter 1:50 CD235a-APC, REA175 Miltenyi Biotec 1:200 CD34-FITC, 581 Beckman Coulter 1:50 CD45-APC, J33 Beckman Coulter 1:50 CD45-APC-Vio770, REA747 Miltenyi Biotec 1:200 CD45-PB, J33 Beckman Coulter 1:50 CD71-FITC, M-A712 BD Pharmingen 1:50 IFNAR1-FITC, MMHAR-1 PBL Assay Science 1:25 IFNAR2-PE, REA124 Miltenyi Biotec 1:25 References 1. .. FORWARD ** AATGATACGGCGACCACCGAG ATCTACACTCTTTCCCTACACG ACGCTC locus-specific amplification SHORT_INT_FOR ** AATGATACGGCGACCACCGAG ATCT locus-specific amplification JAK2_PRIMER1 ** ACCAACCTCACCAACATTACAG AGGCCT locus-specific amplification JAK2_PRIMER2 ** AGGAGACTACGGTCAACTGCA TGAAACAGA locus-specific amplification JAK2_PRIMER3 ** GCAGCAAGTATGATGAGCAAG CTTTCTCACA locus-specific amplification JAK2_PRIMER4 ** GTGACTGGAGTTCAGACGTGT GCTCTTCCGATCTGCAGCAAG TATGATGAGCAA locus-specific amplification Table S4: List of all antibodies used for flow cytometry Antibody, clone Company Dilutio n CD235a-PC7, 11E4B Beckman Coulter 1:50 CD235a-APC, REA175 Miltenyi Biotec 1:200 Flow Cytometry:Article Title: Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa Article Snippet: FORWARD ** AATGATACGGCGACCACCGAG ATCTACACTCTTTCCCTACACG ACGCTC locus-specific amplification SHORT_INT_FOR ** AATGATACGGCGACCACCGAG ATCT locus-specific amplification JAK2_PRIMER1 ** ACCAACCTCACCAACATTACAG AGGCCT locus-specific amplification JAK2_PRIMER2 ** AGGAGACTACGGTCAACTGCA TGAAACAGA locus-specific amplification JAK2_PRIMER3 ** GCAGCAAGTATGATGAGCAAG CTTTCTCACA locus-specific amplification JAK2_PRIMER4 ** GTGACTGGAGTTCAGACGTGT GCTCTTCCGATCTGCAGCAAG TATGATGAGCAA locus-specific amplification Table S4: List of all antibodies used for flow cytometry Antibody, clone Company Dilutio n CD235a-PC7, 11E4B Beckman Coulter 1:50 CD235a-APC, REA175 Miltenyi Biotec 1:200 CD34-FITC, 581 Beckman Coulter 1:50 CD45-APC, J33 Beckman Coulter 1:50 CD45-APC-Vio770, REA747 Miltenyi Biotec 1:200 CD45-PB, J33 Beckman Coulter 1:50 CD71-FITC, M-A712 BD Pharmingen 1:50 IFNAR1-FITC, MMHAR-1 PBL Assay Science 1:25 IFNAR2-PE, REA124 Miltenyi Biotec 1:25 References 1. .. FORWARD ** AATGATACGGCGACCACCGAG ATCTACACTCTTTCCCTACACG ACGCTC locus-specific amplification SHORT_INT_FOR ** AATGATACGGCGACCACCGAG ATCT locus-specific amplification JAK2_PRIMER1 ** ACCAACCTCACCAACATTACAG AGGCCT locus-specific amplification JAK2_PRIMER2 ** AGGAGACTACGGTCAACTGCA TGAAACAGA locus-specific amplification JAK2_PRIMER3 ** GCAGCAAGTATGATGAGCAAG CTTTCTCACA locus-specific amplification JAK2_PRIMER4 ** GTGACTGGAGTTCAGACGTGT GCTCTTCCGATCTGCAGCAAG TATGATGAGCAA locus-specific amplification Table S4: List of all antibodies used for flow cytometry Antibody, clone Company Dilutio n CD235a-PC7, 11E4B Beckman Coulter 1:50 CD235a-APC, REA175 Miltenyi Biotec 1:200 Article Title: Hsa-miR-532-3p protects human decidual mesenchymal stem cells from oxidative stress in recurrent spontaneous abortion via targeting KEAP1 Article Snippet: .. The following markers of hDMSCs were detected by flow cytometry (FC) (BDLSRFortessa): CD3-FITC (1:100, Southern Biotechnology, 9515-02S), CD29-FITC(1:100, Miltenyi, 130-123-692), CD34-FITC( Article Title: Hsa-miR-532-3p protects human decidual mesenchymal stem cells from oxidative stress in recurrent spontaneous abortion via targeting KEAP1. Article Snippet: .. The following markers of hDMSCs were detected by flow cytometry (FC) (BDLSRFortessa): CD3-FITC (1:100, Southern Biotechnology, 9515-02S), CD29-FITC(1:100, Miltenyi, 130-123-692), Clinical Proteomics:Article Title: Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy? Article Snippet: Strategies to improve hematopoietic stem and progenitor cell (HSPC) mobilization from the bone marrow can have a pivotal role in addressing iatrogenic bone-marrow insufficiency from chemo(radio)therapy and overcoming peripheral blood stem cell transplantation (PBSCT) limitations such as insufficient mobilization.. Granulocyte-colony stimulating factor (G-CSF) represents the standard mobilization strategy for HSPC and has done so for more than three decades since its FDA approval.. Its association with non–G-CSF agents is often employed for difficult HSPC mobilization. Control:Article Title: Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy? Article Snippet: Strategies to improve hematopoietic stem and progenitor cell (HSPC) mobilization from the bone marrow can have a pivotal role in addressing iatrogenic bone-marrow insufficiency from chemo(radio)therapy and overcoming peripheral blood stem cell transplantation (PBSCT) limitations such as insufficient mobilization.. Granulocyte-colony stimulating factor (G-CSF) represents the standard mobilization strategy for HSPC and has done so for more than three decades since its FDA approval.. Its association with non–G-CSF agents is often employed for difficult HSPC mobilization. |